Drug-drug interactions arising from the use of liposomal vincristine in combination with other anticancer drugs

Pharm Res. 2001 Sep;18(9):1331-5. doi: 10.1023/a:1013050330608.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antibiotics, Antineoplastic / pharmacokinetics
  • Antineoplastic Agents / administration & dosage
  • Antineoplastic Agents / pharmacokinetics*
  • Antineoplastic Agents, Phytogenic / administration & dosage
  • Antineoplastic Agents, Phytogenic / pharmacokinetics*
  • Drug Carriers
  • Drug Compounding
  • Drug Interactions
  • Female
  • Hydrogen-Ion Concentration
  • Idarubicin / pharmacokinetics
  • Liposomes
  • Mice
  • Vincristine / administration & dosage
  • Vincristine / pharmacokinetics*

Substances

  • Antibiotics, Antineoplastic
  • Antineoplastic Agents
  • Antineoplastic Agents, Phytogenic
  • Drug Carriers
  • Liposomes
  • Vincristine
  • Idarubicin